Bellicum Pharmaceuticals Executives

BLCMDelisted Stock  USD 0.37  0.05  11.90%   
Bellicum Pharmaceuticals employs about 13 people. The company is managed by 6 executives with a total tenure of roughly 35 years, averaging almost 5.0 years of service per executive, having 2.17 employees per reported executive. Analysis of Bellicum Pharmaceuticals' management performance can provide insight into the firm performance.
Richard Fair  CEO
President CEO, Director
Aaron Foster  President
Senior Vice President Head of Research
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Bellicum Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.6114) % which means that it has lost $0.6114 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0613) %, meaning that it created substantial loss on money invested by shareholders. Bellicum Pharmaceuticals' management efficiency ratios could be used to measure how well Bellicum Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Bellicum Pharmaceuticals Workforce Comparison

Bellicum Pharmaceuticals is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 927. Bellicum Pharmaceuticals claims roughly 13.0 in number of employees contributing just under 2% to equities under Health Care industry.

Bellicum Pharmaceuticals Notable Stakeholders

A Bellicum Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bellicum Pharmaceuticals often face trade-offs trying to please all of them. Bellicum Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bellicum Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Richard FairPresident CEO, DirectorProfile
Aaron FosterSenior Vice President Head of ResearchProfile
Alan SmithExecutive Vice President of Technical OperationsProfile
Joseph SenesacVice President - ManufacturingProfile
PharmD MSChief OfficerProfile
Charles GrassPrincipal OfficerProfile

About Bellicum Pharmaceuticals Management Performance

The success or failure of an entity such as Bellicum Pharmaceuticals often depends on how effective the management is. Bellicum Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bellicum management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bellicum management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in Houston, Texas. Bellicum Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people.

Bellicum Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Bellicum Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bellicum Pharmaceuticals within its industry.

Bellicum Pharmaceuticals Manpower Efficiency

Return on Bellicum Pharmaceuticals Manpower

Revenue Per Employee115.4K
Revenue Per Executive250K
Net Loss Per Employee1.9M
Net Loss Per Executive4.2M
Working Capital Per Employee1.5M
Working Capital Per Executive3.3M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Bellicum Pink Sheet

If you are still planning to invest in Bellicum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellicum Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Managers
Screen money managers from public funds and ETFs managed around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device